Single-arm trials for US Food and Drug Administration cancer drug approvals: Although there are some challenges in using single-arm studies for accelerated drug approvals, it can make a difference in getting drugs previously approved for other uses to patients.: Although there are some challenges in using single-arm studies for accelerated drug approvals, it can make a difference in getting drugs previously approved for other uses to patients.
作者信息
Nierengarten Mary Beth
出版信息
Cancer. 2023 Jun 1;129(11):1626. doi: 10.1002/cncr.34830.